At4g00315 Antibody

Shipped with Ice Packs
In Stock

Description

Identification and Context of At4g00315 Antibody

The identifier At4g00315 corresponds to a gene in Arabidopsis thaliana (a model plant organism) within the TAIR (The Arabidopsis Information Resource) database. While this gene is annotated as encoding a protein, no direct references to an "At4g00315 Antibody" are found in the provided search results or publicly available literature. Antibodies targeting plant proteins are less commonly documented in mainstream biomedical research compared to human or animal antibodies.

Key Observations:

  • Gene Function: At4g00315 is annotated as a hypothetical protein in TAIR, with no known functional characterization.

  • Antibody Development: Antibodies targeting plant proteins typically require custom synthesis, as commercial availability is limited.

  • Research Gaps: No peer-reviewed studies, clinical applications, or experimental data for an At4g00315-specific antibody exist in the indexed literature.

Potential Applications and Challenges

If an At4g00315 Antibody were developed, its utility would depend on the protein’s role in Arabidopsis biology. Hypothetical applications include:

ApplicationDescriptionRelevance
Protein LocalizationTracking subcellular localization (e.g., nucleus, chloroplasts) via immunofluorescence.Plant molecular biology research.
Protein InteractionsIdentifying binding partners using co-immunoprecipitation (Co-IP).Functional genomics studies.
Biomarker DevelopmentMonitoring protein expression in stress responses (e.g., drought, pathogens).Agricultural biotechnology.

Challenges:

  • Antigen Specificity: Custom antibodies require validated epitopes, which may not exist for uncharacterized plant proteins.

  • Cross-Reactivity: Plant proteins often share conserved domains, risking off-target binding.

Research Limitations and Recommendations

The absence of At4g00315 Antibody data in the provided sources highlights critical gaps:

  1. Lack of Commercial Availability:

    • No vendors (e.g., Alomone Labs, R&D Systems) list At4g00315-targeting antibodies.

    • Custom production would require collaboration with specialized antibody manufacturers.

  2. Methodological Barriers:

    • Antigen Production: Recombinant At4g00315 protein synthesis is prerequisite for antibody development.

    • Validation: Rigorous testing (e.g., Western blot, immunoprecipitation) is needed to confirm specificity.

Recommendations:

  • Database Cross-Check: Verify the identifier in TAIR or UniProt for updated annotations.

  • Alternative Approaches: Use CRISPR-Cas9 or RNAi to study gene function if antibody development is unfeasible.

  • Collaboration: Partner with plant biology or antibody engineering labs for custom antibody generation.

Comparative Analysis with Documented Antibodies

To contextualize the challenges, compare At4g00315 Antibody with well-characterized antibodies:

FeatureAt4g00315 AntibodyAnti-GABA(A) α4 Receptor Antibody (AGA-008)
Target ProteinHypothetical plant proteinGABA(A) α4 subunit (neurotransmitter receptor)
ApplicationsTheoretical (localization, Co-IP)Western blot, immunohistochemistry, live imaging
Commercial AvailabilityNoneAvailable (Alomone Labs)
Validation DataAbsentBlockade peptide validation, species reactivity

Product Specs

Buffer
Preservative: 0.03% ProClin 300; Constituents: 50% Glycerol, 0.01M Phosphate Buffered Saline (PBS), pH 7.4
Form
Liquid
Lead Time
14-16 week lead time (made-to-order)
Synonyms
At4g00315 antibody; A_IG005I10.18 antibody; F5I10.18Putative F-box/FBD/LRR-repeat protein At4g00315 antibody
Target Names
At4g00315
Uniprot No.

Q&A

What is At4g00315 and why would researchers need an antibody against it?

At4g00315 is a gene locus identifier in Arabidopsis thaliana, referring to a specific gene on chromosome 4. Researchers develop antibodies against proteins encoded by such genes to study their expression, localization, interactions, and functions within plant cells. Antibodies serve as highly specific molecular probes that can detect target proteins in complex biological samples. The development of antibodies against plant proteins follows similar principles to those used for other organisms, involving careful selection of immunogens and validation of specificity .

What types of antibodies are available for plant protein research?

Three main types of antibodies can be used for plant protein research, each with distinct advantages:

  • Polyclonal antibodies: These are derived from multiple B cell clones and recognize multiple epitopes on the target protein. They are typically generated by immunizing animals (often rabbits) with a purified protein or peptide antigen and collecting antibody-rich serum . Polyclonal antibodies often provide higher sensitivity due to their ability to bind multiple epitopes but may have lower specificity.

  • Monoclonal antibodies: These are derived from a single B cell clone and recognize a single epitope. Their production involves animal immunization, collection of B cells, fusion with myeloma cells to create hybridomas, and selection of antibody-producing cell lines . Monoclonal antibodies offer high specificity and consistency between batches.

  • Recombinant antibodies: These are generated through molecular biology techniques, often using phage display libraries. They can be engineered for improved specificity, affinity, and stability .

How can I validate the specificity of an At4g00315 antibody?

Validating antibody specificity is crucial for ensuring reliable experimental results. For plant protein antibodies, including one targeting At4g00315, consider these validation approaches:

  • Western blot with positive and negative controls:

    • Use recombinant At4g00315 protein as a positive control

    • Use protein extracts from knockout/knockdown plants lacking At4g00315

    • Include related proteins to check for cross-reactivity

  • Immunoprecipitation followed by mass spectrometry to confirm target binding

  • Immunohistochemistry with appropriate controls:

    • Compare signal patterns with known expression patterns

    • Include knockout plant tissues as negative controls

  • Pre-absorption controls where the antibody is pre-incubated with purified antigen before use in experiments, which should abolish specific signals

When validating against recombinant proteins, ensure you test reactivity against the actual target rather than just the tag, as some antibodies may recognize fusion tags but not the protein of interest .

What are the optimal sample preparation methods for plant proteins when using antibodies?

Sample preparation is critical for successful antibody-based detection of plant proteins like At4g00315. Plant tissues contain numerous compounds that can interfere with antibody binding or cause non-specific background.

For Western blotting:

  • Use extraction buffers containing appropriate detergents (e.g., SDS, Triton X-100) based on protein localization

  • Include protease inhibitors to prevent protein degradation

  • Add reducing agents (e.g., DTT, β-mercaptoethanol) if detecting denatured epitopes

  • Incorporate PVPP (polyvinylpolypyrrolidone) to remove phenolic compounds

  • Consider tissue-specific optimization, as different plant tissues have varying interfering compounds

For immunohistochemistry:

  • Test multiple fixatives (paraformaldehyde, glutaraldehyde) as they differentially preserve epitopes

  • Optimize antigen retrieval methods for enhanced epitope accessibility

  • Include blocking steps with non-fat dry milk or BSA to reduce non-specific binding

  • Consider using detergents in wash buffers to reduce background

How should antibody dilutions be optimized for different experimental applications?

Antibody dilution optimization is essential for balancing signal-to-noise ratio across different applications. Based on standard practices for plant protein antibodies:

For Western blot:

  • Start with manufacturer's recommended dilution (typically 1:1000 as indicated for similar antibodies)

  • Perform a dilution series (e.g., 1:500, 1:1000, 1:2000, 1:5000)

  • Select the dilution that provides clear specific bands with minimal background

  • Consider extended incubation times (overnight at 4°C) for more dilute antibody solutions

For immunohistochemistry:

  • Begin with higher concentrations than used for Western blot (e.g., 1:100 to 1:500)

  • Test different incubation times and temperatures

  • Optimize secondary antibody dilutions independently

For ELISA:

  • Create a standard curve using recombinant protein

  • Test primary antibody dilutions from 1:100 to 1:10,000

  • Select dilutions within the linear range of detection

Document optimization parameters systematically in a laboratory notebook to ensure reproducibility across experiments.

How can in vitro mutagenesis improve the affinity and specificity of an At4g00315 antibody?

In vitro mutagenesis represents a powerful approach to enhance antibody performance for challenging targets like plant proteins. The process involves:

  • Targeted mutations in complementarity-determining regions (CDRs):

    • Single point mutations in CDRs can significantly improve binding affinity

    • For example, the mutation T57H in one study improved binding affinity by 2.6-fold

    • Multiple CDRs can be mutated in combination for synergistic improvements

  • Selection of improved variants:

    • Convert promising mutants to IgG format for full characterization

    • Assess binding using multiple methods (ELISA, SPR, flow cytometry)

    • Verify that improved affinity translates to enhanced performance in applications

  • Experimental design for mutation screening:

    • Focus on residues directly contacting the antigen

    • Create libraries of mutants targeting specific CDR residues

    • Use high-throughput screening to identify beneficial mutations

This approach allows the development of antibodies with enhanced detection limits and improved specificity, particularly valuable for plant proteins that may be present at low abundance or have closely related family members.

What computational approaches can assist in designing high-affinity antibodies for plant proteins?

Computational methods have revolutionized antibody design, enabling researchers to accelerate the development of high-affinity antibodies for challenging targets like plant proteins. Key approaches include:

  • Machine learning-guided optimization:

    • Feature representation of three-dimensional antigen-antibody interfaces

    • Bayesian optimization algorithms to propose promising mutations

    • Iterative improvement through computational evaluation and experimental validation

  • Molecular dynamics simulations:

    • Evaluation of binding energetics through free energy calculations

    • Assessment of antibody-antigen complex stability

    • Prediction of structural changes upon binding

  • Combined computational-experimental platforms:

    • Initial computational predictions followed by experimental validation

    • Feedback loops to improve predictive models

    • High-throughput calculations on supercomputing systems

In one case study, researchers evaluated 89,263 mutant antibodies computationally from a design space of 10^40 possibilities in just 22 days, allowing them to prioritize 20 candidates for experimental testing . Such approaches could significantly accelerate the development of antibodies against At4g00315 and other plant proteins.

How do post-translational modifications of plant proteins affect antibody recognition?

Post-translational modifications (PTMs) can significantly impact antibody recognition of plant proteins, including potential modifications of At4g00315:

  • Common plant protein PTMs affecting antibody binding:

    • Phosphorylation

    • Glycosylation

    • Ubiquitination

    • Sumoylation

    • Acetylation

  • Strategies for PTM-specific antibodies:

    • Design immunogens that include the specific PTM

    • Use synthetic peptides with the modification of interest

    • Develop separate antibodies that recognize the modified and unmodified forms

    • Perform sequential immunoprecipitation to enrich for modified proteins

  • Experimental considerations:

    • Include phosphatase inhibitors when studying phosphorylated proteins

    • Use glycosidase treatments as controls when studying glycosylated proteins

    • Compare results from native and denaturing conditions, as PTMs may affect protein folding

  • Validation approaches:

    • Use recombinant proteins with and without the PTM

    • Compare results from tissues/conditions where the PTM is known to differ

    • Employ mass spectrometry to confirm the presence or absence of PTMs in samples

What are common causes of non-specific binding when using plant protein antibodies?

Non-specific binding is a frequent challenge when working with plant protein antibodies. Understanding and addressing these issues can significantly improve experimental outcomes:

  • Plant-specific interfering compounds:

    • Phenolic compounds can bind proteins and antibodies non-specifically

    • Secondary metabolites may react with detection reagents

    • High polysaccharide content can cause background signal

  • Cross-reactivity with related proteins:

    • Plant genomes often contain gene families with similar sequences

    • Antibodies raised against conserved domains may recognize multiple family members

    • Sequence similarity between the target and other proteins should be carefully analyzed

  • Solutions to reduce non-specific binding:

    • Increase blocking agent concentration (5-10% non-fat dry milk or BSA)

    • Add detergents (0.1-0.3% Tween-20) to wash buffers

    • Include competing proteins (e.g., from plant species lacking the target)

    • Pre-absorb antibodies with proteins from knockout plants

    • Use more stringent washing conditions (higher salt concentration, longer washes)

  • Controls to identify non-specific binding:

    • Include knockout/knockdown plant material as negative controls

    • Use pre-immune serum or isotype controls

    • Perform competition assays with the immunizing antigen

How should antibodies be stored and handled to maintain optimal activity?

Proper storage and handling are essential for maintaining antibody performance over time:

  • Storage recommendations:

    • Store lyophilized antibodies at -20°C

    • Once reconstituted, make small aliquots to avoid repeated freeze-thaw cycles

    • Add preservatives like 0.02% sodium azide or ProClin to liquid antibodies

    • Keep antibodies away from direct light, especially if conjugated to fluorophores

  • Handling best practices:

    • Briefly centrifuge tubes before opening to collect material that may adhere to the cap

    • Avoid vortexing antibodies; mix by gentle inversion or pipetting

    • Use clean pipette tips for each handling

    • Wear gloves to prevent contamination

  • Quality control measures:

    • Periodically test antibody activity against positive controls

    • Document lot-to-lot variation if using commercial antibodies

    • Monitor background levels as a sign of potential degradation

    • Keep detailed records of antibody performance over time

  • Reconstitution guidelines:

    • Follow manufacturer recommendations for reconstitution volume and buffer

    • For lyophilized antibodies, reconstitute with sterile water or appropriate buffer

    • Allow complete dissolution before aliquoting

How can bispecific antibody technology be applied to plant protein research?

Bispecific antibody technology, while primarily developed for therapeutic applications, offers promising tools for plant research:

  • Potential applications in plant science:

    • Simultaneous detection of two proteins in complex plant extracts

    • Studying protein-protein interactions in planta

    • Creating synthetic proximity between enzymes and substrates

    • Targeting proteins to specific subcellular compartments

  • Design considerations for plant bispecific antibodies:

    • Tetravalent formats (like ATG-101) can provide increased avidity

    • 2+2 configurations allow binding to two different epitopes simultaneously

    • Engineer binding domains with appropriate affinities for each target

    • Consider the accessibility of both epitopes in native conditions

  • Validation approaches:

    • Confirm binding to each target protein individually

    • Verify simultaneous binding capabilities

    • Test in relevant plant tissue/cellular contexts

    • Compare performance to standard antibodies for each target

  • Technical challenges:

    • Expression systems may need optimization for plant-specific antibodies

    • Stability in plant extracts may differ from other research contexts

    • May require specialized detection systems for certain applications

What quantitative approaches can be used to determine antibody affinity for plant proteins?

Accurate determination of antibody affinity is essential for characterizing interactions with plant proteins and optimizing experimental conditions:

  • Surface Plasmon Resonance (SPR):

    • Provides real-time measurement of association and dissociation kinetics

    • Determines kon and koff rates and calculates KD

    • Requires purified antigen and antibody

    • Yields absolute affinity values in controlled conditions

  • Bio-Layer Interferometry (BLI):

    • Similar to SPR but with different detection principle

    • Allows for higher throughput screening

    • Can work with crude samples in some configurations

    • Uses less sample than traditional SPR

  • Flow cytometry-based approaches:

    • Measures binding to cell-surface or intracellular proteins

    • Calculates relative affinity based on mean fluorescence intensity

    • Can be performed on cells expressing the target protein

    • Formula: MFI = function of antibody concentration

  • ELISA-based methods:

    • Affinity determination through titration curves

    • Scatchard analysis of binding data

    • Competitive ELISA for comparing relative affinities

    • Suitable for high-throughput screening

  • Isothermal Titration Calorimetry (ITC):

    • Measures thermodynamic parameters of binding

    • Provides KD, ΔH, ΔS values

    • Requires no labeling or immobilization

    • Uses relatively large amounts of sample

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.